Cancer Therapeutics and Novel Approaches


The generally existing therapies in malignant growth treatment are seriously identified with many results and are profoundly noxious, which will decrease the personal satisfaction. This coordinates the creation of novel methodologies in disease treatment. Malignancy immunotherapy is the most significant methodology, in which the actuation of invulnerable framework happens for the therapy of malignancy. Customarily the Cytokine treatment considered as a spine of immunotherapy. The antibodies like peptide vaccines, tumors cell immunizations, safe cell immunizations, malignant growth antibodies are evaluate as a writer finding in disease field. The receptive cell treatment in hematologic harm is thought as training for disease treatment. The sub-atomic malignancy treatment is additionally a novel methodology in disease treatment. Tumor Immunology assumes a significant part in decision of new disclosures for cancer therapeutics. Preventive Cancer Conference communicates its work to battle malignant growth.



 


  • Low Dose Computer Tomography (LDCT)
  • Screening Profile

Related Conference of Cancer Therapeutics and Novel Approaches

November 25-26, 2024

7th International Conference on Anti-Cancer Drugs & Therapies

Vancouver, Canada
November 28-29, 2024

14th World Congress on Breast Cancer

Paris, France
December 10-11, 2024

8th Global Meeting on Oncology and Radiology

Dubai, UAE
December 11-12, 2024

34th Experts Meet On Cancer Research & Therapy

Paris, France
December 12-13, 2024

44th Euro Congress on Cancer Science & Therapy

Rome, Italy
March 10-11, 2025

3rd World Congress on Oral Cancer

Paris, France
March 24-25, 2025

25th World Congress on Cancer and Diagnostics

London, UK
March 24-25, 2025

10th World Conference on Breast and Cervical Cancer

Paris, France
June 16-17, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands

Cancer Therapeutics and Novel Approaches Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in